Delivery Order SPE2DB22D2211-SPE2DB25FSBTB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,690.77 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count bottles) on July 30, 2025, with completion scheduled for July 31, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order falls under the company's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a $1,479.44 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Methylphenidate ER 36 mg tablets in a quantity of 100 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,438.08 for methylphenidate ER 36 mg tablets (100-count supply) on July 22, 2025, with ultimate completion by July 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count) under a firm fixed-price contract valued at $1,362.35. This non-set-aside competitive award, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a routine pharmaceutical procurement through the federal medical supply chain. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,186.76 for Methylphenidate ER 36 mg tablets (100-count) on August 1, 2025, with completion scheduled for August 4, 2025. This competitively awarded, firm fixed-price delivery order was placed without set-aside designations and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The pharmaceutical product supports federal medical supply requirements, primarily serving military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count packages) with a contract value of $2,196.52. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively determined. The order is scheduled for completion by July 23, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $1,471.36 delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 18 mg tablets (100-count) on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Methylphenidate ER 18 mg tablets (100-count bottles) with a firm fixed price ceiling value of $1,810.72. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for Methylphenidate ER 54 mg tablets in quantities of 100, with a firm fixed price ceiling value of $2,311.33 and an ultimate completion date of August 4, 2025. This competitive award, which involved no set-aside designation, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,043.04 to AmerisourceBergen Drug Corp for Methylphenidate ER 36 mg tablets (100 count) on July 22, 2025, with a completion date of July 23, 2025. This non-set-aside, firm fixed price delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSBTBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Methylphenidate ER 54 mg tablets (100-count bottles) with a ceiling value of $1,386.06. This firm fixed-price delivery order, which is expected to be completed by July 30, 2025, represents a competitive procurement with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. As a prime pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems and other government agencies. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical supply requirements through open competition, positioning it as a key partner in the Defense Health Agency's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/29/25 |